Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(25 sites)
United States
Rocky Mountain Cancer Centers, LLP, Aurora, Colorado Rocky Mountain Cancer Centers, LLP, Denver, Colorado Rocky Mountain Cancer Centers, LLP, Lone Tree, Colorado Sarah Cannon Research Institute, Nashville, Tennessee SCRI Oncology Partners, Nashville, Tennessee